invasive bladder cancer in an attempt to improve functional outcomes and complication
rates over open radical cystectomy (ORC). We performed a meta-analysis of randomized
controlled trials (RCTs) to compare patient outcomes between RARC and ORC. The primary
outcome measure was a composite of recurrence-free survival (RFS) or progression-free
survival (PFS). As a secondary measure, we examined other surrogate oncologic endpoints …